FORMULATION, CHARACTERIZATION AND COMPARATIVE IN VITRO IN VIVO EVALUATION OF SUSTAINED RELEASE THEOPHYLLINE TABLETS
暂无分享,去创建一个
[1] A. Rahman,et al. Full Proceeding Paper EFFECT OF FABRICATION TECHNIQUES ON DEGRADATION AND DRUG RELEASE PROFILE OF POLYANHYDRIDES , 2011 .
[2] S. Sarojini,et al. Research Article BUOYANT SUSTAINED RELEASE TABLETS BASED ON POLYETHYLENE OXIDE , 2010 .
[3] N. Barakat,et al. Controlled-Release Carbamazepine Matrix Granules and Tablets Comprising Lipophilic and Hydrophilic Components , 2009, Drug delivery.
[4] P. S. Hiremath,et al. Oral Controlled Release Formulations of Rifampicin. Part II: Effect of Formulation Variables and Process Parameters on In Vitro Release , 2008, Drug delivery.
[5] Mohammad Barzegar-Jalali,et al. Design and evaluation of 1- and 3-layer matrices of verapamil hydrochloride for sustaining its release , 2005, AAPS PharmSciTech.
[6] Mohammad Safiqul Islam,et al. In vitro Release Kinetics Study of Diltiazem Hydrochloride from Wax and Kollidon SR Based Matrix Tablets , 2008 .
[7] S. B. Tiwari,et al. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system , 2008, AAPS PharmSciTech.
[8] V. Meidan,et al. Drug Release Kinetics from Tablet Matrices Based Upon Ethylcellulose Ether-Derivatives: A Comparison Between Different Formulations , 2007, Drug development and industrial pharmacy.
[9] F. Al-Jenoobi,et al. EFFECTS OF SPHERE SIZE, POLYMER TO DRUG RATIO AND PLASTICIZER CONCENTRATION ON THE RELEASE OF THEOPHYLLINE FROM ETHYLCELLULOSE MICROSPHERES , 2007 .
[10] R. Lockey,et al. Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline , 2006, Respiratory research.
[11] S. Willsie. A Prospective Clinical Study of Theophylline Safety in 3810 Elderly With Asthma or COPD , 2006 .
[12] T. Sonobe,et al. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. , 2005, International journal of pharmaceutics.
[13] P. Mura,et al. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets. , 2005, Farmaco.
[14] M. Shamsipur,et al. A novel potentiometric sensor for selective determination of theophylline: Theoretical and practical investigations , 2005 .
[15] L. Valvo,et al. Diclofenac sodium multisource prolonged release tablets--a comparative study on the dissolution profiles. , 2005, Journal of pharmaceutical and biomedical analysis.
[16] E. Franceschinis,et al. Preparation and in vitro/in vivo characterisation of a melt pelletised paracetamol/stearic acid sustained release delivery system , 2004 .
[17] A. Ohnishi,et al. Differential Pharmacokinetics of Theophylline in Elderly Patients , 2003, Drugs & aging.
[18] J. Álvarez-Fuentes,et al. Development of sustained release matrix tablets of didanosine containing methacrylic and ethylcellulose polymers. , 2002, International journal of pharmaceutics.
[19] S. Al-suwayeh,et al. Excipient-Excipient Interaction in the Design of Sustained-Release Theophylline Tablets: In Vitro and In Vivo Evaluation , 2001, Drug development and industrial pharmacy.
[20] Adolfina Ruiz Martínez,et al. In vitro evaluation of isopropylbenzylsalicylate-polymer interaction in topical formulation , 2001 .
[21] J. Varshosaz,et al. Biopharmaceutical characterization of oral theophylline and aminophylline tablets. Quantitative correlation between dissolution and bioavailability studies. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[22] M. Shannon. Theophylline: Its rise, demise, and resurrection , 2000 .
[23] G. Ertan,et al. Modeling of theophylline release from different geometrical erodible tablets. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[24] A S Hussain,et al. Identification of critical formulation and processing variables for metoprolol tartrate extended-release (ER) matrix tablets. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[25] S. Neau,et al. Sustained release theophylline tablets by direct compression: Part 1: formulation and in vitro testing , 1998 .
[26] S. Nutini,et al. Long-term treatment of asthmatic patients with salmeterol vs slow-release theophylline. , 1998, Respiratory medicine.
[27] Hisakazu Sunada,et al. Controlled-release of diclofenac sodium from wax matrix granule , 1996 .
[28] M. Ghorab,et al. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 5. Theophylline. , 1996, Die Pharmazie.
[29] S. Neau,et al. Ethylcellulose matrix controlled release tablets of a water-soluble drug , 1995 .
[30] H. Ammar,et al. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 1. Allopurinol. , 1995, Die Pharmazie.
[31] K. Florey,et al. Analytical profiles of drug substances and excipients , 1992 .
[32] M. Friedman,et al. Inhibition of plaque formation by a sustained release delivery system for cetylpyridinium chloride , 1988 .
[33] C. Shim,et al. Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters. , 1987, Journal of pharmaceutical sciences.
[34] R. Pauwels. The effects of theophylline on airway inflammation. , 1987, Chest.
[35] T. Higuchi. MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. , 1963, Journal of pharmaceutical sciences.